Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02380742 · ClinicalTrials.gov registry record · Phase 2
Topical Anesthetic Use In Pessary Management
A Phase 2 study, sponsored by Loyola University.
- Completed
- Registry status
- Phase 2
- Development phase
- 54
- Enrollment target
NCT02380742 is a Phase 2 study that has completed, run by Loyola University. The registered enrollment target is 54 participants.
The verdict
NCT02380742, a Phase 2 study, has completed, sponsored by Loyola University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate if lidocaine-prilocaine (EMLA 5%) cream can reduce pain and discomfort at the time of vaginal pessary removal and insertion. Half of the participants will receive lidocaine-prilocaine (EMLA 5%) cream and the other half will receive a placebo cream.
Interventions
- DRUG Placebo cream
- DRUG lidocaine-prilocaine cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02380742
The ClinicalTrials.gov registry entry for NCT02380742 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loyola University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo cream is the first listed.
NCT02380742 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02380742 about?
NCT02380742 is a clinical study titled "Topical Anesthetic Use In Pessary Management". The purpose of this study is to evaluate if lidocaine-prilocaine (EMLA 5%) cream can reduce pain and discomfort at the time of vaginal pessary removal and insertion. Half of the participants will receive lidocaine-prilocaine (EMLA 5%) cream and the other half will receive a placebo cream.
What is the current status of trial NCT02380742?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 54 participants. The study started on 2015-07. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02380742?
The interventions under investigation include: Placebo cream (DRUG), lidocaine-prilocaine cream (DRUG).
Who is sponsoring clinical trial NCT02380742?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.